{
     "PMID": "28457579",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20171128",
     "LR": "20171128",
     "IS": "1558-1497 (Electronic) 0197-4580 (Linking)",
     "VI": "55",
     "DP": "2017 Jul",
     "TI": "Amyloidosis and neurodegeneration result in distinct structural connectivity patterns in mild cognitive impairment.",
     "PG": "177-189",
     "LID": "S0197-4580(17)30099-4 [pii] 10.1016/j.neurobiolaging.2017.03.023 [doi]",
     "AB": "Alzheimer's disease (AD) is increasingly considered as a disconnection syndrome. Previous studies of the structural connectome in early AD stages have focused on mild cognitive impaired subjects (MCI), considering them as a homogeneous group. We studied 168 subjects from the Alzheimer's Disease Neuroimaging Initiative database (116 MCI and 52 cognitively normal subjects). Biomarker-based stratification using amyloid biomarkers (AV45 PET) and neurodegeneration biomarkers (MRI and FDG PET) led to 4 subgroups based on amyloid positivity (A+/-) and neurodegeneration positivity (N+/-): A-N-, A+N-, A-N+, and A+N+. Using diffusion MRI, we showed that both MCI A-N+ and MCI A+N+ subjects displayed an alteration of the white matter in the fornix and a significant bihemispheric network of decreased connections. These network alterations in MCI A+N+ are stronger and more focal than those of MCI A-N+. Only MCI A+N+ subjects exhibited specific changes in hippocampal connectivity and an AD-like alteration pattern. Our results indicate that the connectome disintegration pattern of MCI subgroups differ with respect to brain amyloid and neurodegeneration. Each of these 2 AD biomarkers induces a connectome alteration that is maximal when they coexist.",
     "CI": [
          "Copyright (c) 2017 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Jacquemont, Thomas",
          "De Vico Fallani, Fabrizio",
          "Bertrand, Anne",
          "Epelbaum, Stephane",
          "Routier, Alexandre",
          "Dubois, Bruno",
          "Hampel, Harald",
          "Durrleman, Stanley",
          "Colliot, Olivier"
     ],
     "AU": [
          "Jacquemont T",
          "De Vico Fallani F",
          "Bertrand A",
          "Epelbaum S",
          "Routier A",
          "Dubois B",
          "Hampel H",
          "Durrleman S",
          "Colliot O"
     ],
     "AD": "Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Departement de Biologie, Ecole normale superieure, PSL Research University, F-75005, Paris, France. Electronic address: t.jacquemont44@gmail.com. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Department of Neuroradiology, AP-HP, Hopital de la Pitie-Salpetriere, Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Department of Neurology, AP-HP, Hopital de la Pitie-Salpetriere, Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Department of Neurology, AP-HP, Hopital de la Pitie-Salpetriere, Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Department of Neurology, AP-HP, Hopital de la Pitie-Salpetriere, Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Paris, France; AXA Research Fund & UPMC Chair, Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France. Inserm, U1127, Paris, France; CNRS, UMR 7225 ICM, Paris, France; Sorbonne Universites, UPMC Univ Paris 06, UMR S 1127, Paris, France; Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France; Inria, Aramis project-team, Centre de Recherche de Paris, France; Department of Neuroradiology, AP-HP, Hopital de la Pitie-Salpetriere, Paris, France; Department of Neurology, AP-HP, Hopital de la Pitie-Salpetriere, Institut de la Memoire et de la Maladie d'Alzheimer (IM2A), Paris, France. Electronic address: olivier.colliot@upmc.fr.",
     "CN": [
          "Alzheimer's Disease Neuroimaging Initiative"
     ],
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170405",
     "PL": "United States",
     "TA": "Neurobiol Aging",
     "JT": "Neurobiology of aging",
     "JID": "8100437",
     "RN": [
          "0 (Biomarkers)",
          "Amyloid angiopathy"
     ],
     "SB": "IM",
     "MH": [
          "Aged",
          "Aged, 80 and over",
          "Alzheimer Disease/*complications/diagnostic imaging",
          "Biomarkers",
          "Cerebral Amyloid Angiopathy/*complications/diagnostic imaging",
          "Cognition/*physiology",
          "Cognitive Dysfunction/diagnostic imaging/*etiology/pathology/*psychology",
          "Connectome",
          "Diffusion Magnetic Resonance Imaging",
          "Female",
          "Hippocampus/diagnostic imaging/physiopathology",
          "Humans",
          "Male",
          "Middle Aged",
          "Nerve Degeneration/*complications/diagnostic imaging",
          "Positron-Emission Tomography"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's disease",
          "Biomarkers",
          "MCI",
          "Network analysis",
          "Structural connectome"
     ],
     "EDAT": "2017/05/02 06:00",
     "MHDA": "2017/11/29 06:00",
     "CRDT": [
          "2017/05/02 06:00"
     ],
     "PHST": [
          "2016/09/27 00:00 [received]",
          "2017/03/17 00:00 [revised]",
          "2017/03/19 00:00 [accepted]",
          "2017/05/02 06:00 [pubmed]",
          "2017/11/29 06:00 [medline]",
          "2017/05/02 06:00 [entrez]"
     ],
     "AID": [
          "S0197-4580(17)30099-4 [pii]",
          "10.1016/j.neurobiolaging.2017.03.023 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neurobiol Aging. 2017 Jul;55:177-189. doi: 10.1016/j.neurobiolaging.2017.03.023. Epub 2017 Apr 5.",
     "term": "hippocampus"
}